Surgical treatment of a non-obese patient with type 2 diabetes - Primary experience - A case report

Wideochirurgia I Inne Techniki Maloinwazyjne

Volumn 6, Issue 2, 2011, Pages 99-102

  Proczko Markuszewska, Monika ^a   Kaska, Łukasz ^a   Stefaniak, Tomasz ^a   Śledziński, Zbigniew ^a   Łachiński, Andrzej J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Effect of incretins; Gastric bypass; Glycated haemoglobin; Non obese patient; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CASE REPORT; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROJEJUNOSTOMY; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; ROUX Y ANASTOMOSIS; STOMACH BYPASS; STOMACH POUCH;

EID: 79960209147     PISSN: 18954588     EISSN: None     Source Type: Journal    
DOI: 10.5114/wiitm.2011.23217     Document Type: Article

References (17)

1. Dadan J, Iwacewicz P, Hady Razak Hady. Quality of life evaluation after selected bariatric procedures using the Bariatric Analysis and Reporting Outcome System. Videosurgery and other miniinvasive techniques 2010; 5: 93-9.
2. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 1-11. (Pubitemid 38176365)
3. American Diabtes Association - www.diabetes.org. Stanowisko Amerykańskiego Towarzystwa Diabetologicznego dotycza̧ce badań opublikowanych w czasopiśmie Diabetologia, czerwiec 2009.
4. Rubino F. Is type 2 diabetes an operable intestinal disease. Diab Care 2008; 31 (Suppl. 2): S290-6.
5. IX Meeting Surgical Continous Education and XIV Nutrition Which surgical procedure should be carried out for type 2 diabetes. Malaga 17-19 February 2010.
6. Matuszek B, Lenart-Lipińska M, Nowakowski A. Incretin hormones in the treatment of diabetes type 2. New possibilities for pharmacotherapy of diabetes type 2. Pol J Endocrinol 2008; 59: 322-9.
7. Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C. Biological actions of incretins GIP and GIP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab 2005; 31: 233-42. (Pubitemid 40961520)
8. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/ resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009; 35: 518-23.
9. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010; 61: 393-411.
10. Laferrere B. Effect of gastric bypass surgery on the incretins. Diabetes Metab 2009; 35: 513-7.
11. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-56.
12. Kwiatkowski A, Paśnik K, Stanowski E, Badyda A. Regression of metabolic syndrome depending on type of bariatric surgery. Videosurgery and other miniinvasive techniques 2009; 42: 53-8.
13. DePaula ALV, Macedo V, Schraibman BR, et al. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients BMI 20-34. Surg Endosc 2009; 23: 1724-32.
14. Schauer PR, Burguera B, Ikramudin S, et al. Effect of Laparoscopic Roux-En Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-85. (Pubitemid 38176385)
15. Ferzli GS, Dominique E, Ciaglia M, et al. Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg 2009; 33: 972-9.
16. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for non-obese type 2 patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 2009; 19: 1077-83.
17. 2: an integrative review of early studies. Obes Surg 2010; 20: 776-90.